Evidence map›Paper›PMID 41103658›Full record

ArticleFrontiers in endocrinology2025

Distribution of prolactin and its correlation with insulin resistance in women with polycystic ovary syndrome.

Stefan Ghobrial, Robert Krysiak, Tal Goldstein, Antonella Patsch, Chiara Paternostro, Florian Heinzl, Rodrig Marculescu, Johannes Ott

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stefan GhobrialClinical Division of Gynecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, Vienna, Austria.
Robert KrysiakDepartment of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.
Tal GoldsteinClinical Division of Gynecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, Vienna, Austria.
Antonella PatschDepartment of Obstetrics and Gynecology, Landesklinikum Wiener Neustadt, Wiener Neustadt, Lower Austria, Austria.
Chiara PaternostroDepartment of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
Florian HeinzlDepartment of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
Rodrig MarculescuDepartment of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Johannes OttClinical Division of Gynecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Polycystic ovary syndrome (PCOS) is often associated with insulin resistance (IR). The role of prolactin (PRL) in this context remains unclear, particularly across different PCOS phenotypes. The aim of this study was to investigate the distribution of PRL, as well as its correlation with basal IR in women with PCOS. Methods: 200 women with PCOS, evenly distributed across phenotypes A-D and matched for age and body mass index (BMI) were retrospectively analyzed. PRL, Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), sexual hormone binding globulin (SHBG), testosterone, and BMI were assessed. Correlation analysis and unsupervised clustering (based on PRL and HOMA-IR) were performed. Results: PRL levels were similar across phenotypes, but phenotype D had a significantly lower prevalence of HOMA-IR ≥ 2.5 (p = 0.032). PRL was inversely correlated with HOMA-IR in all groups (p < 0.05). Cluster analysis identified three distinct subgroups, independent of phenotype, differing significantly in both PRL and HOMA-IR. Conclusion: PRL is inversely associated with IR in PCOS, regardless of phenotype. Cluster analysis reveals metabolic subtypes not captured by current phenotype-based classification, suggesting potential for improved risk stratification.

Indexed as

Insulin ResistancePolycystic Ovary SyndromeProlactinAdultBody Mass IndexFemaleHumansRetrospective StudiesSex Hormone-Binding GlobulinTestosteroneYoung AdultProlactinSex Hormone-Binding GlobulinTestosteroneHOMA-IRhyperprolactinemiainsulin resistancepolycystic ovary syndromeprolactin

Identifiers

PMID41103658
PMCPMC12520901

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.